Trends in Medical Affairs – BMS, Sanofi, Takeda, Microsoft….
Disruptive technologies are transforming every aspect of healthcare – doctors diagnose differently, regulators assess differently and pharma develops drugs differently.
How does a role increasingly demanded across this whole system adapt to these changes and continue to thrive?
In this latest Medical Affairs paper understand how medical must champion real-world evidence, artificial intelligence, digital health and adapt to a changing healthcare environment – to reach its full value potential. Find it here: https://goo.gl/VqEkXm
Some of the contributors to this 13-page paper include:
• Shontelle Dodson, SVP, Medical Affairs, Americas, Astellas
• Gundula Scheindewind, VP, Medical Affairs EU & Canada, Takeda
• Bozidar Jovicevic, VP, Global Head Digital Medicines, Sanofi
• Stanislav Glezer, CMO, Adocia
• Lav Parvathenani, Director of Publications and Scientific Content, BMS
• Iain Buchan, Director of Healthcare Research, Microsoft
You can get your free copy of the full paper here: https://goo.gl/VqEkXm
How does a role increasingly demanded across this whole system adapt to these changes and continue to thrive?
In this latest Medical Affairs paper understand how medical must champion real-world evidence, artificial intelligence, digital health and adapt to a changing healthcare environment – to reach its full value potential. Find it here: https://goo.gl/VqEkXm
Some of the contributors to this 13-page paper include:
• Shontelle Dodson, SVP, Medical Affairs, Americas, Astellas
• Gundula Scheindewind, VP, Medical Affairs EU & Canada, Takeda
• Bozidar Jovicevic, VP, Global Head Digital Medicines, Sanofi
• Stanislav Glezer, CMO, Adocia
• Lav Parvathenani, Director of Publications and Scientific Content, BMS
• Iain Buchan, Director of Healthcare Research, Microsoft
You can get your free copy of the full paper here: https://goo.gl/VqEkXm
